Stock Report

Dr. Reddy's Laboratories Ltd updates on USFDA PAI at its biologics facility



Posted On : 2023-10-12 21:34:37( TIMEZONE : IST )

Dr. Reddy's Laboratories Ltd updates on USFDA PAI at its biologics facility

The United States Food & Drug Administration (USFDA) today completed a product specific Pre-Approval Inspection (PAI) at our biologics manufacturing facility in Bachupally, Hyderabad.

The inspection was conducted from October 4, 2023 to October 12, 2023. We have been issued a Form 483 with nine observations, which we will address within the stipulated timeline.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 5529.90 as compared to the previous close of Rs. 5567.25. The total number of shares traded during the day was 3499 in over 753 trades.

The stock hit an intraday high of Rs. 5599.95 and intraday low of 5518.35. The net turnover during the day was Rs. 19390004.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 RDY USFDA Inspection Biologics ManufacturingFacility